Stride FY26 net income rises 17.5% to $338.19 million; revenue increases 4.7% to $2.52 billion
LRN•Stride reports FY26 and fourth-quarter results
- Stride posts Q4 net income attributable to common stockholders of $81.39 million, up 58.6%, with diluted EPS of $1.75, up 69.9%.
- Revenue slips 2.7% to $636.06 million, while operating income more than doubled to $105.85 million.
- Full-year net income attributable to common stockholders climbs 17.5% to $338.19 million, lifting diluted EPS 20% to $7.14.
- Full-year revenue rises 4.7% to $2.52 billion; operating income increases 25.2% to $450.77 million.
- Average full-year enrollments rise 4.2% to 243,900, while cash and marketable securities total $1.03 billion and share repurchases reach $188.7 million.
Related News
Liminatus Pharma annual meeting draws 48.31% of shares represented
LIMN•
Intrepid Potash Q2 FY26 net income from continuing operations rises 71.43% to $2.4 million; sales from continuing operations slip 1.19% to $66.7 million
IPI•
